Canexis Pharma AG’s Post

Discover the latest trends and insights shaping the dynamic world of medicinal cannabis. Gaining valuable knowledge to enhance patient care and stay at the forefront of this evolving industry. https://lnkd.in/guk2S4RC #cannabisindustry #medicalcannabis #cbdoil #cannabisindustry #cbd #MedicinalCannabisTrends #MedicalCannabis #HealthcareInnovation #cannabisbusiness

SOMAÍ Pharmaceuticals has introduced its first product line, Oral Solutions, to Australian patients. Our innovative extracts are available through numerous distributors across Australia, such as The Entourage Effect, Novachem, Leafio, and Aeris Health. This is the first product line in the broadest medicinal cannabis portfolio to be available this year. To meet patient's evolving needs, we launch new products to the Australian market each month, including Oral Solution Proprietary Formulations, Oral Spray lines, Soft Gel Capsules, Inhalation Oil cartridges, and more. At SOMAÍ Pharmaceuticals, our primary goal is to revolutionise global medicinal cannabis markets by delivering exceptional products that cater to the diverse needs of patients. #SOMAÍ #GMP #medicalcannabis #biotechnology #medicalcannabismarket #manufacturing #pharmtech #medicalcannabisnews 

The size of global clinical microbiology market in terms of revenue was estimated to be worth $5.0 billion in 2024 and is poised to reach $6.9 billion by 2029, growing at a CAGR of 6.5% from 2024 to 2029. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dvFJvhWW 𝐃𝐫𝐢𝐯𝐞𝐫𝐬: ◾ Increasing legalization of medical and recreational cannabis ◾ Increasing use of cannabis for medicinal applications ◾ Technological advancements in testing technologies #NorthAmerica accounted for the largest share of 65.5% of the cannabis testing market in 2023. 𝐓𝐡𝐞 𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚𝐧 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐚 𝐯𝐚𝐥𝐮𝐞 𝐨𝐟 𝐔𝐒𝐃 2.6 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029 𝐟𝐫𝐨𝐦 𝐚𝐧 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐯𝐚𝐥𝐮𝐞 𝐨𝐟 𝐔𝐒𝐃 1.2 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2024, 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 17.3% 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝. The region leads the cannabis testing market due to stringent regulatory standards, robust infrastructure, and widespread legalization of cannabis for medical and recreational purposes. Additionally, North America’s advanced R&D capabilities and evolving consumer demand for quality assurance drive its prominence in this growing sector. 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Agilent Technologies, SHIMADZU CORPORATION, Thermo Fisher Scientific, Danaher Corporation, Waters Corporation, Restek Corporation, SGS Switzerland SA), PerkinElmer, Hamilton Company, Sigma Analytical Services, SC Labs, PHARMLABS LLC, MCS, ProVerde Laboratories, and Eurofins Scientific Finland Oy #CannabisTesting #CannabisIndustry #CannabisScience #CannabisResearch #CannabisLabs #CannabisSafety #CannabisQuality #CannabisCompliance #LabTesting #CannabisRegulations #CannabisMarket #MedicalCannabis #CannabisTechnology #CannabisStandards #CannabisAnalysts

🔊 𝗟𝗼𝗼𝗸𝗶𝗻𝗴 𝘁𝗼 𝗼𝗽𝘁𝗶𝗺𝗶𝘇𝗲 𝘆𝗼𝘂𝗿 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗮𝗹 𝗰𝗮𝗻𝗻𝗮𝗯𝗶𝘀 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻 𝗽𝗿𝗼𝗰𝗲𝘀𝘀? 👉👉 Discover how our innovative drying cabinet maximizes CBD production. Designed specifically for medicinal cannabis, it ensures a precise and controlled drying process, preserving valuable terpenes and cannabinoids. Our dryer, tailored for the pharmaceutical industry, provides an 𝗼𝗽𝘁𝗶𝗺𝗮𝗹 𝗚𝗠𝗣 𝗲𝗻𝘃𝗶𝗿𝗼𝗻𝗺𝗲𝗻𝘁 for drying and curing cannabis flowers. Every parameter, from temperature and humidity to airflow, is 𝗳𝘂𝗹𝗹𝘆 𝗽𝗿𝗼𝗴𝗿𝗮𝗺𝗺𝗮𝗯𝗹𝗲 to guarantee a precise and controlled drying process. 🔎 𝗪𝗵𝘆 𝗶𝘀 𝘁𝗵𝗶𝘀 𝗶𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝘁 𝗳𝗼𝗿 𝗖𝗕𝗗 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝘀? ✏️ 𝗣𝗿𝗲𝘀𝗲𝗿𝘃𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝘁𝗲𝗿𝗽𝗲𝗻𝗲𝘀: Terpenes are aromatic compounds that, along with cannabinoids like CBD, contribute to the entourage effect and the plant's therapeutic properties. Our dryer helps preserve these valuable compounds, ensuring that final products are more complete and effective. ✏️ 𝗖𝗼𝗻𝘀𝗶𝘀𝘁𝗲𝗻𝗰𝘆 𝗶𝗻 𝗲𝘃𝗲𝗿𝘆 𝗯𝗮𝘁𝗰𝗵: Uniformity in the drying process is essential to ensure consistency in the quality and potency of CBD products. Our technology produces homogeneous batches, facilitating quality control and traceability. ✏️ 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗰𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲: Operating under strict GMP standards, we guarantee that our equipment meets the most demanding regulatory requirements, ensuring the safety and efficacy of CBD products produced with our solutions. 💻  https://bit.ly/4eoNfIX At Albian, we are committed to innovation and quality. Our cannabis dryer is a clear example of how technology can significantly improve production processes and the quality of CBD products. 𝘿𝙤 𝙮𝙤𝙪 𝙝𝙖𝙫𝙚 𝙦𝙪𝙚𝙨𝙩𝙞𝙤𝙣𝙨 𝙖𝙗𝙤𝙪𝙩 𝙤𝙪𝙧 𝙙𝙧𝙮𝙞𝙣𝙜 𝙘𝙖𝙗𝙞𝙣𝙚𝙩? Our team of experts is happy to answer all your questions. 𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝘂𝘀 or 𝘃𝗶𝘀𝗶𝘁 𝘂𝘀 𝗮𝘁 𝗙𝗮𝗿𝗺𝗮𝗳𝗼𝗿𝘂𝗺, 𝗯𝗼𝗼𝘁𝗵 𝗘𝟱𝟮-𝗙𝟱𝟭, for p͟e͟r͟s͟o͟n͟a͟l͟i͟z͟e͟d͟ ͟a͟t͟t͟e͟n͟t͟i͟o͟n͟!͟ #cannabis #cbd #hemp #cannabinoids #medicalcannabis #cannabisindustry #cannabisdryer #AlbianGroup #CBDproducts #pharma #medicalcannabis #industriacannabis #cannabismedicinal #cannabisindustry #cannabisequipment #pharmaindustry

A new study highlights the cannabis entourage effect, exploring how various compounds within the plant, such as flavonoids, terpenes, and cannabinoids, interact to enhance its therapeutic benefits. This research heightens the complexity of cannabis and the potential for creating more effective medical treatments through understanding these interactions. It's a significant step toward leveraging cannabis in natural plant medicine, emphasizing the need for further investigation into the ratios and effects of these compounds. Tap the link in the comments to read more. #cbd #cbdoil #hemp #brandprotection #cannabis

𝟐𝟎𝟐𝟒 𝐜𝐨𝐧𝐭𝐢𝐧𝐮𝐞𝐬 𝐭𝐨 𝐛𝐞 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐯𝐞 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐜𝐚𝐧𝐧𝐚𝐛𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲. Last week saw the DEA reclassify cannabis as a schedule 3 controlled substance on par with codeine and testosterone. However, the term "cannabis industry" may be holding back progress. At Phytome Life Sciences, we focus on developing licensed medicines that can be prescribed and reimbursed. We prefer clear sectors and business models. Here are the sectors we find useful: 1️⃣ Pharmaceutical: Prescription-only medicines approved by regulatory bodies like the FDA and EMA based on clinical trial data. 2️⃣ Medical: Unlicensed cannabinoid extracts used to treat medical conditions with a prescription from a healthcare provider. 3️⃣ Wellness: Consumer use of cannabinoids for well-being, with limited data to support claims, including supplements and skincare products. 4️⃣ Recreational: Consumer use of cannabis for intoxication, whether legally or through the black market. Our aim is to be part of the wider conversation, but spearhead our sector of botanical medicine. #PhytomeLifeSciences #biotech #Innovation

European medicinal cannabis manufacturing powerhouse SOMAÍ Pharmaceuticals is set to shake up the Australian market with a range of products designed to create new standards in the quality and variety of cannabinoid medicine. SOMAÍ will invest A$1.6 million in the market, with chairman and CEO Michael Sassano explaining the company is setting itself up in Australia with a long-term vision to hold patient interest by introducing a consistent supply while showcasing innovative cannabis formats. “I want Australia to know that SOMAÍ is here to stay and will supply product lines that prescribers and patients currently do not have, while eliminating worries that inventories will run out,” shares Michael with Cannabiz. Read the full article: https://lnkd.in/dnv8tai6 #SOMAÍ #GMP #medicalcannabis #biotechnology #medicalcannabismarket #manufacturing #pharmtech #medicalcannabisnews #medicalcannabisEU #medicalcannabisaustralia

🚀 The Global Cannabis Testing Market is Poised for Growth! 🚀 The market is projected to grow at a robust rate of 15-17% by 2029. For more insights, get your sample report here: https://lnkd.in/dXAmxTxG Key factors fueling this expansion include: 🌿 Legalization of medical cannabis. 🔬 Increasing number of cannabis testing laboratories, especially in the U.S. 📊 Growing adoption of Laboratory Information Management Systems (LIMS). 🌍 Government support in LATAM and the Middle East & Africa. However, challenges such as limited awareness about medical cannabis and high startup costs for testing laboratories could impact growth. Major players shaping this market include Agilent Technologies, Inc., Shimadzu Corporation, MERCK KGAA, Thermo Fisher Scientific, DigiPath, Inc., Steep Hill Inc., SC Laboratories, Inc., and PharmLabs LLC. #CannabisTesting #MarketGrowth #MedicalCannabis #LIMS #MarketInsights #HealthcareInnovation #CannabisIndustry #LaboratoryTesting #CannabisScience #RegulatoryCompliance #GlobalHealth #BioTech #CannabisResearch #MarketTrends #EmergingMarkets #PharmaTech #HealthTech #LATAM #MiddleEast #Africa #MedicalMarijuana #CannabisTherapy #CannabisMedicine #Cannabinoids #THC #CBD #PatientCare #AlternativeMedicine #HerbalMedicine #PainManagement #ChronicPain #EpilepsyTreatment #MentalHealth #CancerTreatment #MedicalResearch #CannabisBenefits #NaturalMedicine #HealthWellness #ClinicalStudies #TherapeuticCannabis #PatientAdvocacy #LegalCannabis #CannabisLegislation #MedicalCannabisCommunity

A real RegOps boss moment that I had in my professional career was spearheading the simultaneous submissions of Global Regulatory Marketing Applications for two very important products for a small company! This meant managing the submission of 8 large applications across 4 countries within weeks of each other. The key was strategizing documentation to use what we had to develop what we needed for the various regional requirements and label strategies. But even since then, I have learned so much more. We want to help your team boss up their Ops moves to get things done when timelines are tight! Ask SWOT about innovative strategies like working with your CMC strategist to repurpose your IMPD for the Module 3 eCTD with a little RegOps magic! #Regulatory #Operations #CMC #Global